Results 121 to 130 of about 29,657 (272)
Structural and Functional Aspects of Class A Carbapenemases. [PDF]
, 2016 The fight against infectious diseases is probably one of the greatest public health challenges faced by our society, especially with the emergence of carbapenem-resistant gram-negatives that are in some cases pan-drug resistant.
Dortet, L, Iorga, BI, Naas, T
core +3 more sources
Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii
Brazilian Journal of Microbiology, 2016 Acinetobacter baumannii is widely recognized as an important pathogen associated with nosocomial infections. The treatment of these infections is often difficult due to the acquisition of resistance genes. A. baumannii presents a high genetic plasticity which allows the accumulation of these resistance determinants leading to multidrug resistance.
Pagano, Mariana +2 more
openaire +4 more sources
Infection and Drug ResistanceIl Kwon Bae, Jun Sung Hong Department of Companion Animal Health and Science, Silla University, Busan, South KoreaCorrespondence: Jun Sung Hong, Department of Companion Animal Health and Science, Silla University, 140 Baegyang-Daero (Blvd), 700beon-Gil ...
Bae IK, Hong JS
doaj
Carbapenemase genes in clinical and environmental isolates of Acinetobacter spp. from Quito, Ecuador [PDF]
PeerJCarbapenem-resistant Acinetobacter spp. is associated with nosocomial infections in intensive care unit patients, resulting in high mortality. Although Acinetobacter spp.
Nicole Sotomayor +5 more
doaj +2 more sources
Clonal diversity of Acinetobacter baumannii from diabetic patients in Saudi Arabian hospitals [PDF]
, 2014 Carbapenem-resistant Acinetobacter baumannii (CR-AB) represents a major health-care problem causing high rates of morbidity and mortality. This study investigated the clonality of CR-AB isolated from diabetic patients from different regions in Saudi ...
Abdalhamid +11 more
core +2 more sources
Carbapenem-resistant Acinetobacter baumannii in Latin America
Acinetobacter baumannii is an important bacterial pathogen associated with healthcare-associated infections (HAIs), especially in critically ill patients admitted to Intensive Care Units (ICU). Its ability to acquire antibiotic resistance determinants has propelled its clinical relevance. The rise in Acinetobacter infections and hospital outbreaks have
Thiago Pavoni Gomes Chagas +2 more
openaire +1 more source
Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii
Frontiers in Cellular and Infection MicrobiologyPatients with severe carbapenem-resistant Acinetobacter baumannii (CRAB) infections currently face significant treatment challenges. When patients display signs of infection and the clinical suspicion of CRAB infections is high, appropriate treatment should be immediately provided. However, current treatment plans and clinical data for CRAB are limited.
Siqin Zhang +4 more
openaire +3 more sources
Infection and Drug Resistance, 2018 Chih-Cheng Lai,1 Chi-Chung Chen,2,3 Ying-Chen Lu,3 Yin-Ching Chuang,2,4 Hung-Jen Tang5,6 1Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan; 2Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan ...
Lai CC +4 more
doaj
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii group in Taiwan
mSphereAcinetobacter, particularly the Acinetobacter baumannii group, is a major cause of nosocomial infections, and carbapenem-resistant Acinetobacter spp. are important human pathogens. We collected 492 Acinetobacter spp.
Tran Lam Tu Quyen +5 more
doaj +1 more source